Peer-delivered program tied to improvements in quality of life, physical activity, pain.
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Telemedicine instead of office visit did not change outcomes in patients with suboptimal glycemic control.
Benefits seen for diabetes remission, weight loss, changes in metabolic parameters.
The Mediterranean Diet was ranked as the best diet overall for 2020, according to new rankings released by US News and World Report.
Consumption of 4 cups of coffee per day linked to loss of fat mass, reduction in urinary creatinine.
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
Assessment of suicide risk as part of routine pediatric type 1 diabetes care is feasible and necessary.
Increased risk for GDM seen across all levels of prepregnancy BMI and gestational weight gain.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
Significant links persisted after adjustment for markers of nutritional quality, metabolic comorbidities.
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.
Children of women with diabetes diagnosed before or during pregnancy are at increased risk for early-onset cardiovascular disease.
The risk for type 1 and type 2 diabetes from childhood into adulthood is increased in preterm-born individuals.
The high prevalence of overweight and obesity in youth with T1D was consistent across a multinational cohort and persistent over time.
Prevalence of prediabetes 18.0 and 24.0% among adolescents and young adults, respectively.
Timing of exercise and the consumption of mixed-macronutrient breakfast or carbohydrates may have acute and chronic effects on metabolic processes for men who are overweight or obese.
Findings independent of adolescent obesity and further tied to diabetes diagnosis at younger age.
Variation in prevalence of eye exams from 43.9% in Puerto Rico to 64.8% in Rhode Island.
Agency says new generic versions could create competition that would drive down prices.